Europe Advanced Wound Care Market

Europe Advanced Wound Care Market Size (2022 to 2027)

The size of the European Advanced Wound Care Market is estimated to be worth USD 3.67 billion by 2027 and USD 2.93 billion in 2022, growing at a CAGR of 4.63% during the forecast period.

The major factors driving the advanced wound care market in the European region are the growing incidence of injured wounds and the rising number of surgeries like cesareans. In addition, the increasing prevalence of diabetes cases is one of the key factors propelling Europe advanced wound care market. According to World Health Organization (WHO), nearly 60 million people have diabetes in the European region,, and 15% of diabetic people suffer from diabetic ulcers. For such patients, advanced wound care treatment is one of the best ways to heal faster than other procedures. Advanced wound care for diabetic ulcers includes debridement of necrotic tissue, infection control, ulcer care, and management of blood glucose levels.

YOY rise in the aging population in the European region, growing patient count suffering from chronic wounds, and increasing adoption of technological advancements are expected to promote the growth rate of the advanced wound care market in the European region. Chronic ulcers are the most painful part of their body. It will affect the quality of life and produce disturbance in the body system. Chronic wounds may include venous leg ulcers and pressure ulcers. Some common for all types of ulcers are excessive inflammation, persistent infections, formation of drug-resistant microbial biofilms. All these types of wounds must require advanced wound care treatment, which is only available in the hospital and specialized centers. The incidences of various types of Ulcers, such as Pressure Ulcers, leg Ulcers, foot Ulcers, etc., vary between 0.07% to 0.09%. Also, 0.24% of the population in Europe is experiencing Chronic Wounds. In 2018, around 19% of the European population aged 65 and more.

Furthermore, the adoption of advanced wound care treatment is increasing among the patient population suffering from obesity, further resulting in market growth in this region. People who are obese would have less healing capacity for wounds. The 2022 Regional Obesity Report by World Health Organization (WHO) says an estimated 59% of adults in Europe are obese in 2022. Increasing adoption of technological advancements to manufacture products and devices for advanced wound care treatment is expected to favor the market's growth rate. 

On the other hand, the high costs associated with advanced wound care treatments are hampering the market growth. Due to the high cost of the treatment, most people prefer to avoid having advanced wound care treatment, which is slowing the market's growth rate from achieving its full potential. Furthermore, the lack of awareness around advanced wound care among the European population inhibits the market’s growth rate. In addition, the availability of alternative devices and inadequate infrastructure facilities in rural areas impede the market growth. Furthermore, reimbursement issues and cost issues serve as factors that hinder the market in Europe. There are inadequate reimbursement policies undertaken by the government, hampering the market's growth rate.

This research report on the European advanced wound care market has been segmented and sub-segmented into the following categories:

Europe Advanced Wound Care Market - By Type:

• Dressings
• Therapy Devices
• Active wound care

Based on type, the dressing segment is expected to register a leading share of the European advanced wound care market during the forecast period.

Europe Advanced Wound Care Market - By Application:

• Skin Ulcers
• Surgical Wounds
• Burn Wounds

The skin ulcers segment is anticipated to dominate the other segments in the European market during the forecast period.

Europe Advanced Wound Care Market - By End-User:

• In-patient services
• Out-patient services

Europe Advanced Wound Care Market - By Country:

• UK
• France
• Spain
• Germany
• Italy
• Russia
• Sweden
• Denmark
• Switzerland
• Netherlands
• Turkey
• Czech Republic
• Rest of Europe

Regionally, Europe captured the second-largest share of the global market in 2021. The advanced wound care market in this region has more significance, with trends showing that people desire more efficient solutions for their illnesses. This technology is especially inclined toward the elderly population in Europe, for whom easily accessible healthcare is paramount. In addition, several awareness programs have been conducted in Europe to increase awareness of advanced wound care treatments among the public. These programs explain the types of chronic wounds and the related treatment that can heal the wound as early as possible.

Within Europe, Germany advanced wound care market is projected to lead. It is expected to continue its dominance throughout the period owing to the growing adoption of technological developments and growing initiatives from the German governments towards wound care research fuelling the market. Moreover, increasing demand for active wound care products and their treatment, particularly those in emerging nations, are likely to offer better opportunities. However, the cost associated with the procedure is so expensive it can’t be affordable. Also, inadequate reimbursement policies towards the market may hamper the growth of this country in this region. A wound care summit was held in Germany to develop wound care products. Increasing hospitals and clinics with the new advanced wound care treatment in Germany also drives the market forward.

The UK advanced wound care market is expected to have a rapid CAGR growth during the period, and the increase is due to the growing occurrence of diabetes, which leads to the market growth of this region. The other factors include lifestyle disorders like foot ulcers, pressure ulcers, and venous ulcers, which propel the market. In the UK, every year, nearly 3.8 million people have diabetes. Moreover, product approvals and advancements in product technologies drive the UK market. The UK-based company Advanced Medical Solution Group plc has received FDA acceptance for high-performance dressing and silicone PHMB dressings from the US, which will assist in the ease of launching the products in the market to specific regions that may also influence the market growth. Every year around 2.2 million adults in the UK are found to have a wound, and the number of wound cases in the UK increases with the highest CAGR. In the United Kingdom, there are nearly 2.2 million people who are suffering from chronic wounds. The UK also increased specialist centers for the treatment of chronic wounds and increased clinical trials. They also use robotics and imaging to improve surgery and wound healing.

KEY MARKET PARTICIPANTS:

A few of the notable companies operating in Europe advanced wound care market are Acelity L.P., Inc., Smith and Nephew Plc., Mölnlycke Health Care, ConvaTec, Coloplast Corp., 3M Healthcare, Medtronic, Integra Lifesciences Corporation, and Organogenesis Inc.